Van beleggers
voor beleggers
desktop iconMarkt Monitor

Ontvang nu dagelijks onze kooptips!

word abonnee

Aandeel RELIEF THERAPEUTICS N ZSE:RLF.CH, CH0100191136

  • 0,029 2 dec 2022 17:30
  • +0,000 (+1,38%) Dagrange 0,028 - 0,029
  • 1.516.814 Gem. (3M) 3,8M

Forum Relief therapeutics geopend

2 Posts
| Omlaag ↓
  1. IEX - Forummoderator 31 maart 2021 06:00
    ABOUT US
    Relief is a biopharmaceutical company founded by former Merck executives (Serono division) whose objective is to provide patients with therapeutic relief in serious diseases with high unmet medical need.

    We focus on clinical-stage programs based on molecules of natural origin (peptides and proteins) with a history of clinical use (well-established safety and tolerability) and either initial human activity with efficacy data (proof-of-concept) or a strong scientific rationale. Our most advanced programs involve our lead compound RLF-100™, a synthetic human vasoactive intestinal peptide (VIP) with multifaceted mode of action, in respiratory indications: COVID-19 induced lung injury with major near-term milestones and pulmonary sarcoidosis, two diseases for which no transformational therapy exists. Clinical development of RLF-100™ for other indications in both acute and chronic lung diseases are in planning stages.

    Groet Henk
2 Posts
|Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord

Direct naar Forum

RELIEF THERAPEUTICS N Meer »

Koers 0,029   Verschil +0,00 (+1,38%)
Laag 0,028   Volume 1.516.814
Hoog 0,029   Gem. Volume 3.788.752
2 dec 2022 17:30
Premium drie voorbeelden van IEX Premium: de exclusieve content op de site, de app op een smartphone en IEX Magazine.

KOPEN OF VERKOPEN?

Het laatste advies leest u als IEX Premium-lid

Ontdek Premium

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links